Emmanuelle Vidal-Petiot

86% of subjects are not abnormal ! New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence our piece published today in Circulation ahajournals.org/doi/full/10.11… #hypertension #prevention @EmmaVP5

@dguerrot @LMarilucy @sfhta @com_SFNDT @Sautenet 🙏 venant du grand pédagogue de la néphro, quel honneur !

🚨 #JobAlert Assistant spécialiste aux Explorations Fonctionnelles Rénales @hopitalbichat dès novembre 2024 👉 DFG, exploration des troubles phosphocalciques, hydro-électrolytiques... 👉 HTA (IIR et résistante, centre d'Excellence Européen) 👉 Infos et contact: DM @EmmaVP5

This Core Curriculum by Susan L. Murray and Myles Wolf reviews the physiology and pathophysiology of calcium and phosphate disorders through a series of cases, including clinical conundrums commonly encountered by nephrologists: buff.ly/3Ns2PIG (FREE) @DukeKidney

Hypertension is an risk factor for coronary events, stroke, heart failure, and ESKD. This study found the effects of intensive systolic BP lowering on cardiovascular end points and mortality in SPRINT were independent of time-varying diuretics use bit.ly/CJASN0406

Testing for 385 genes among 1623 CKD patients identified variants in 20.8%, half of whom had new or changed diagnosis, 90.7% change in management, and 32.9% change in treatment bit.ly/JASN0249 @ndahl48 @HilaMilo @fouadchebib @MayoClinicNeph @ColumbiaKidney

SPRINT trial is now validated by ESPRIT RCT from China in high risk HTN including DM pts. Lowering SBP <120 compared with <140 reduces MACE by 12% , CVD death by 39%, all cause death by 21% #AHA23 🎉

Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure: buff.ly/40nDkxi @PAWellingMD @HopkinsMedicine #Nephrology

Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism @DrJunYang @AmarLaurence @WuCent ahajrnls.org/3EYPqmV

New review🫶🙌 with @EdinburghBean Salt Sensitivity: Causes, Consequences, and Recent Advances | Hypertension ahajournals.org/doi/abs/10.116…

New somatic mutation in Primary Aldosteronism. Zinc transporter 1 (ZnT1) gene SLC30A1. Congratulations @adina_turcu and group. nature.com/articles/s4158…

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality @NEJM nejm.org/doi/10.1056/NE…

Happy to share this review just published in @ajprenal that covers the history of NCC and the development of knowledge along the years. doi.org/10.1152/ajpren…

Editorial: A New Dawn for Aldosterone as a Therapeutic Target in Hypertension ja.ma/3Pe3LQS #Hypertension23

Happy to share that our paper led by talented IM chief resident @KyleOMalleyMD "Diagnostic performance of the adrenal vein to IVC aldosterone ratio in classifying the subtype of PA" is published in Hypertension Research. @UTSWIMchief @Kazuomi_Kario great journal IF >5 and no OA

Attending the excellent Aldosterone session at #Hypertension23? Check out this State-Of-the-Art review from @AnandVaidya17 and colleagues academic.oup.com/ajh/article/35…

New and old GFR equations: a European perspective academic.oup.com/ckj/article/16… A little story of estimating GFR...free access

New Research: Renal K+ retention in physiological circumstances: focus on adaptation of the distal nephron and cross-talk with Na+ transport systems #Physiology frontiersin.org/articles/10.33…

Very interesting review in Pharmacology and Therapeutics by Kettritz and Loffing: "Potassium homeostasis–Physiology and Pharmacology in a clinical context." doi.org/10.1016/j.phar…

@dguerrot @escardio @sfhta @SebastienRubin @com_SFNDT @SABOURETCardio @AnastasiaSMihai @CCF_cardio @CJNephro @AmarLaurence @Rboulestreau Great summary Dominique 👏